Table 2 Diagnostic efficacy of ECV, ALBI, and MELD-Na for controls and subclassified cirrhosis groups.

From: Estimating liver cirrhosis severity with extracellular volume fraction by spectral CT

  

AUC

Cutoff value

Sensitivity (%)

Specificity (%)

PPV (%)

NPV (%)

Youden

Control vs. cirrhosis

ECV

0.911 (0.858 to 0.949)

29.46

76.38 (68.0–83.5)

95.56 (84.9–99.5)

98.0 (92.9–99.8)

58.9 (46.8–70.3)

0.719

ALBI

0.878 (0.819 to 0.923)

-2.65

80.31 (72.3–86.8)

88.89 (75.9–96.3)

95.3 (89.4–98.5)

61.5 (48.6–73.3)

0.692

MELD_Na

0.868 (0.810 to 0.911)

6

88.98 (82.2–93.8)

71.11 (55.7–83.6)

89.7 (83.0–94.4)

69.6 (54.2–82.3)

0.601

Child-Pugh A vs. B

ECV#

0.901 (0.827 to 0.951)

33.72

78.72 (64.3–89.3)

87.93 (76.7–95.0)

84.1 (69.9–93.4)

83.6 (71.9–91.8)

0.667

ALBI

0.847 (0.764 to 0.910)

-1.87

57.45 (42.2–71.7)

98.28 (90.8–100.0)

96.4 (81.7–99.9)

74.0 (62.8–83.4)

0.557

MELD_Na

0.772 (0.680 to 0.848)

8

78.72 (64.3–89.3)

62.07 (48.4–74.5)

62.7 (49.1–75.0)

78.3 (63.6–89.1)

0.408

Child-Pugh B vs. C

ECV#

0.966 (0.892 to 0.995)

39.53

90.91 (70.8–98.9)

95.74 (85.5–99.5)

90.9 (70.8–98.9)

95.7 (85.5–99.5)

0.867

ALBI

0.906 (0.811 to 0.963)

-1.5

81.82 (59.7–94.8)

89.36 (76.9–96.5)

78.3 (56.3–92.5)

91.3 (79.2–97.6)

0.712

MELD_Na

0.868 (0.764 to 0.937)

12

86.36 (65.1–97.1)

70.21 (55.1–82.7)

57.6 (39.2–74.5)

91.7 (77.5–98.2)

0.566

  1. ECV extracellular volume fraction, ALBI albumin-bilirubin, MELD-Na model of end-stage liver disease with the incorporation of sodium.
  2. #Represents the diagnostic efficacy is statistically significant (p<0.05).